Evidence map›Paper›PMID 41632391›Full record

ArticleDiscover oncology2026

Assessing causal relationships between iron level, disorders of iron metabolism, and hepatocellular carcinoma: a Mendelian randomisation study : The first author.

Sifan Dong, Xujia Wang, Shiqi An, Yongmei Hu, Junzhi Xiao, An Jiang

Abstract read
In one paragraph

Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sifan DongDepartment of Hepatobiliary Pancreas and Liver Transplantation, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.ORCID https://orcid.org/0009-0000-8195-0339
Xujia WangDepartment of Hepatobiliary Pancreas and Liver Transplantation, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.ORCID https://orcid.org/0009-0003-8873-223X
Shiqi AnDepartment of Hepatobiliary Pancreas and Liver Transplantation, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.ORCID https://orcid.org/0009-0000-0846-6081
Yongmei HuDepartment of Hepatobiliary Pancreas and Liver Transplantation, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.ORCID https://orcid.org/0009-0002-6202-457X
Junzhi XiaoDepartment of Hepatobiliary Pancreas and Liver Transplantation, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
An JiangDepartment of Hepatobiliary Pancreas and Liver Transplantation, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. jiangan@xjtu.edu.cn.ORCID https://orcid.org/0000-0001-5844-4972

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmerging evidence indicates that elevated systemic iron levels and dysregulated iron metabolism are closely associated with the pathogenesis of hepatocellular carcinoma (HCC). Observational studies have linked iron overload (e.g., hereditary hemochromatosis) to an increased risk of HCC, potentially mediated through iron-induced oxidative stress, DNA damage, and chronic inflammatory responses. However, the causal relationship between specific iron-related factors-such as organ-specific iron accumulation, systemic iron metabolism disorders, or exogenous iron exposure (dietary/drug iron)-and HCC development remains unconfirmed. MATERIALS AND

methodsThe data of genome-wide association studies (GWAS) involving a variety of human iron content indicators were collected and summarized, covering multiple dimensions such as liver iron content, spleen iron content, pancreas iron content, dietary iron content, drug iron content, and serum iron content, and the information related to genetic diseases of iron metabolism was also included. To explore the potential causal association between iron metabolism disorders and the risk of HCC using two-sample univariate and multivariate Mendelian randomization (MR) techniques. The inverse variance weighting (IVW) method was used as the main analysis method.

resultsNo significant level of pleiotropy was detected according to the MR pleiotropy residual test. Cochran's Q test and MR-Egger regression analysis did not find evidence of heterogeneity and directional pleiotropy of single nucleotide polymorphisms (SNPs). The results of univariate MR Estimation based on the IVW. method show that Liver iron content (OR = 1.0009, CI = 1.0005-1.0013, p = 9.6499e-06) and disorders of iron metabolism (OR = 1.0000, CI = 1.0000-1.0001, P = 4.0417e-08) were the causes of liver cancer. There was no evidence of a causal relationship between drug iron(OR = 1.0176, CI = 0.9612-1.0773, p = 0.5486), dietary iron(OR = 0.9843, CI = 0.9683-1.0007, p = 0.0603) and HCC. Multivariate MR Estimation results based on the IVW method showed that no significant causal association was found between liver iron content, spleen iron content, pancreas iron content, serum iron content, iron metabolism disorder, and HCC risk after using the IVW method.

conclusionsThe univariate results may reflect the complexity of the true association, which needs to be further explored in combination with other methods.

Indexed as

Disorders of iron metabolismHepatocellular carcinomaIronMendelian randomization

Identifiers

PMID41632391
PMCPMC12961066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.